Crinetics Pharmaceuticals, Inc. (CRNX) Financials
CRNX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 635.4 million | 96.2 million |
| 2023-09-30 | 641.5 million | 93.8 million |
| 2023-06-30 | 293.3 million | 39.1 million |
| 2023-03-31 | 314.0 million | 33.7 million |
CRNX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -39.5 million | 11.6 million |
| 2023-09-30 | -44.8 million | 11.0 million |
| 2023-06-30 | -46.0 million | 10.2 million |
| 2023-03-31 | -40.7 million | 8.1 million |
CRNX Net Income
No data available :(
CRNX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 558.6 million | - | 51.7 million |
| 2023-09-30 | 554.7 million | - | 52.2 million |
| 2023-06-30 | 264.5 million | - | 2.6 million |
| 2023-03-31 | 296.1 million | - | 2.8 million |
CRNX Shares Outstanding
CRNX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 935000 | 45.3 million | 17.1 million | - |
| 2023-09-30 | 3.5 million | 43.8 million | 15.5 million | - |
| 2023-06-30 | 237000 | 40.6 million | 13.3 million | - |
| 2023-03-31 | 16000 | 38.5 million | 12.2 million | - |
CRNX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | - | 262000 |
| 2023-09-30 | 346000 | 273000 |
| 2023-06-30 | 988000 | 398000 |
| 2023-03-31 | 2.7 million | 398000 |
CRNX
Price: $47.20
52 week price:
Earnings Per Share: -3.69 USD
P/E Ratio: -10.14
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 265100
Market Capitalization: 3.7 billion